A Proteoliposome Containing Apolipoprotein A-I Mutant (V156K) Enhances Rapid Tumor Regression Activity of Human Origin Oncolytic Adenovirus in Tumor-Bearing Zebrafish and Mice

Bishayee, 2010, Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepato-carcinogenesis, Cancer Prev. Res, 3, 753, 10.1158/1940-6207.CAPR-09-0171

Cattaneo, 2008, Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded, Nat. Rev. Microbiol, 6, 529, 10.1038/nrmicro1927

Cho, K.H. (2009a). Synthesis of reconstituted high-density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL. Mol. Cells 27, 291-297

Cho, K.H. (2009b). Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications. BMB Rep. 42, 393-400.

Cho, 2011, Enhanced delivery of rapamycin by V156K-apoA-I high-density lipoprotein inhibits cellular pro-atherogenic effects and senescence and promotes tissue regeneration, J. Gerontol. A. Biol. Sci. Med. Sci, 66, 1274, 10.1093/gerona/glr169

Cho, 2009, A reconstituted high-density lipoprotein containing V156K or R173C apoA-I exhibited antiinflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation, Exp. Mol. Med, 41, 417, 10.3858/emm.2009.41.6.047

Cho, 2006, ApoA-I mutants V156K and R173C promote antiinflammatory function and antioxidant activities, Eur. J. Clin. Invest, 36, 875, 10.1111/j.1365-2362.2006.01737.x

Cho, 2007, A point mutant of apolipoprotein A-I, V156K, exhibited potent anti-oxidant and anti-atherosclerotic activity in hypercholesterolemic C57BL/6 mice, Exp. Mol. Med, 39, 160, 10.1038/emm.2007.18

Feitsma, 2008, Zebrafish as a cancer model, Mol. Cancer Res, 6, 685, 10.1158/1541-7786.MCR-07-2167

Han, 2005, Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states, J. Lipid Res, 46, 589, 10.1194/jlr.M400468-JLR200

Hitt, 1994, 479

Kapuscinski, 1990, Interactions of nucleic acids with fluorescent dyes: spectral properties of condensed complexes, J. Histochem. Cytochem, 38, 1323, 10.1177/38.9.1696951

Kim, 2010, Severely modified lipoprotein properties without a change in cholesteryl ester transfer protein activity in patients with acute renal failure secondary to Hantaan virus infection, BMB Rep, 43, 535, 10.5483/BMBRep.2010.43.8.535

Kumar, 2008, Virus combinations and chemotherapy for the treatment of human cancers, Curr. Opin. Mol. Ther, 10, 371

Le, 2007, Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish, Proc. Natl. Acad. Sci. USA, 104, 9410, 10.1073/pnas.0611302104

Mizgireuv, 2006, Transplantable tumor lines generated in clonal zebrafish, Cancer Res, 66, 3120, 10.1158/0008-5472.CAN-05-3800

Nusslein-Volhard, 2002

Owusu-Ansah, 2008, Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint, Nat. Genet, 4, 356, 10.1038/ng.2007.50

Park, 2011, A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins, Fish Shellfish Immunol, 31, 904, 10.1016/j.fsi.2011.08.006

Park, 2010, Enhanced delivery of an adenovirus using proteoliposomes containing WT or V156K apolipoprotein A-I and dimyristoylphosphatidylcholine, Hum. Gene Ther, 21, 579, 10.1089/hum.2008.207

Patel, 2010, Anti-inflammatory effects of apolipoprotein A-I in the rabbit, Atherosclerosis, 212, 392, 10.1016/j.atherosclerosis.2010.05.035

Petrella, 2002, A zebrafish coxsackievirus and adenovirus receptor homologue interacts with coxsackie B virus and adenovirus, J. Virol, 76, 10503, 10.1128/JVI.76.20.10503-10506.2002

Spitsbergen, 2000, Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N′-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages, Toxicol. Pathol, 28, 716, 10.1177/019262330002800512

Su, 2010, Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer, Proc. Natl. Acad. Sci. USA, 107, 19997, 10.1073/pnas.1009010107

Tardif, 2009, High-density lipo-protein/apolipoprotein A-I infusion therapy, Curr. Atheroscler. Rep, 11, 58, 10.1007/s11883-009-0009-7

Thomas, 2006, Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors, Cancer Res, 66, 1270, 10.1158/0008-5472.CAN-05-3497

Toth, 2010, Increasing the efficacy of oncolytic adenovirus vectors, Viruses, 2, 1844, 10.3390/v2091844

Toth, 2010, Oncolytic (replication-competent) adenoviruses as anticancer agents, Exp. Opin. Biol. Ther, 10, 353, 10.1517/14712590903559822

Yang, 1994, Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy, Proc. Natl. Acad. Sci. USA, 91, 4407, 10.1073/pnas.91.10.4407

Yoon, 2012, A point mutant of apolipoprotein A-I (V156K) showed enhancement of cellular insulin secretion and potent activity of facultative regeneration in zebrafish, Rejuvenation Res, 15, 313, 10.1089/rej.2011.1246